Technology
DATA
Effective Prophylaxis for 30+ Days with a single dose
Therapeutic concentrations over an extended period of time
Zero order release with 60 days projected therapeutic window
COMPARABLE
A proven approach: Teaching an old drug new tricks with a novel delivery mechanism.
POPULATION
10k - 20k in US
FORMULATION
Proprietary
DELIVERY
Lung, Inhalation
MARKET CAP
$3.8B (NAS:INSM)
Premium
PRODUCT TYPE
Amikacin (Broad-spectrum, Generic)
DRUG
Outpatient, Effective, Low Side Effects
VALUE
PRODUCT TYPE
POPULATION
DRUG
FORMULATION
DELIVERY
VALUE
MARKET CAP
Premium
2.5M in US (250x)
Amikacin (Broad-spectrum, Generic)
Proprietary
Bladder, Installation
Outpatient, Effective, Low Side Effects
-
